Takeda Yakuhin Kogyo KK header image

Takeda Yakuhin Kogyo KK

TAK

Equity

ISIN null / Valor 11292411

New York Stock Exchange, Inc (2025-11-21)
USD 14.30+1.71%

Takeda Yakuhin Kogyo KK
UMushroom community rating:

star star star star star
5.00 2 votes No rating yet
NegativeNeutralPositive

About company

Takeda Yakuhin Kogyo KK, commonly known as Takeda Pharmaceuticals, is a global, research-driven pharmaceutical company with its origins in Osaka, Japan, where it was founded in 1781 by Chobei Takeda I. Initially known for selling traditional Japanese and Chinese herbal medicines, Takeda has evolved into a leader in the pharmaceutical industry, focusing on oncology, gastroenterology, neuroscience, and rare diseases, among other therapeutic areas.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

7.28%1Y
1.63%3Y
-18.5%5Y

Performance

20.5%1Y
18.7%3Y
19.9%5Y

Volatility

Market cap

45176 M

Market cap (USD)

Daily traded volume (Shares)

4,069,846

Daily traded volume (Shares)

1 day high/low

13.25 / 13.155

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

5.00

2 votes
Performance:
starstarstarstarstar
4.00
Innovation:
starstarstarstarstar
3.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
3.00
Adam Hakimi Bin Hasni
United Kingdom, 04 Nov 2025
star star star star star
A good company for long term investment as pharmaceutical and healthcare is a much needed service in Japan
sofia nava
Switzerland, 29 Oct 2025
star star star star star
.

EQUITIES OF THE SAME SECTOR

Edwards Lifesciences Corp
Edwards Lifesciences Corp Edwards Lifesciences Corp Valor: 1065343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.24%USD 85.13
Dyne Therapeutics Inc
Dyne Therapeutics Inc Dyne Therapeutics Inc Valor: 56806425
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.27%USD 21.18
Boiron SA
Boiron SA Boiron SA Valor: 487646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.95%EUR 26.60
Bright Horizons Family Solutions
Bright Horizons Family Solutions Bright Horizons Family Solutions Valor: 19920287
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.62%USD 101.12
Dr Reddy'S Laboratories Ltd
Dr Reddy'S Laboratories Ltd Dr Reddy'S Laboratories Ltd Valor: 1221723
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%USD 13.91
SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA SCHOTT Pharma AG & Co. KGaA Valor: 128964250
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.66%EUR 18.44
Coloplast A/S
Coloplast A/S Coloplast A/S Valor: 20259063
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.55%DKK 580.20
MannKind Corp
MannKind Corp MannKind Corp Valor: 35935511
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.21%USD 5.03
Essity AB
Essity AB Essity AB Valor: 36851944
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.79%SEK 260.90
Lifco Ab
Lifco Ab Lifco Ab Valor: 111355378
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.18%SEK 342.20